DrugPatentWatch Database Preview

Lansoprazole - Generic Drug Details

What are the generic drug sources for lansoprazole and what is the scope of lansoprazole freedom to operate?

Lansoprazole is the generic ingredient in seven branded drugs marketed by Ajanta Pharma Ltd, Breckenridge Pharm, Dr Reddys Labs Ltd, Inventia Hlthcare, Krka Tovarna Zdravil, Labs Liconsa, Lannett Co Inc, Mylan Pharms Inc, Natco Pharma Ltd, Perrigo R And D, Sandoz, Sun Pharm Inds Ltd, Teva Pharms, Wockhardt Ltd, Wockhardt Usa, Zydus Hlthcare, Takeda Pharms Usa, Glaxosmithkline Cons, Takeda Pharms Na, Ani Pharms Inc, Dexcel Pharma, Teva Pharms Usa, and Zydus Pharms Usa Inc, and is included in thirty-two NDAs. There are six patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Lansoprazole has seventy-two patent family members in nineteen countries.

There are fifty-six drug master file entries for lansoprazole. Eighty-three suppliers are listed for this compound.

Summary for lansoprazole

International Patents:	72
US Patents:	6
Tradenames:	7
Applicants:	23
NDAs:	32
Drug Master File Entries:	56
Suppliers / Packagers:	83
Bulk Api Vendors:	96
Clinical Trials:	128
Patent Applications:	6,812
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for lansoprazole
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for lansoprazole
DailyMed Link:	lansoprazole at DailyMed

Pharmacology for lansoprazole

Drug Class	Proton Pump Inhibitor
Mechanism of Action	Proton Pump Inhibitors
Physiological Effect	Inhibition Gastric Acid Secretion

Medical Subject Heading (MeSH) Categories for lansoprazole

Anti-Ulcer Agents
Proton Pump Inhibitors

Synonyms for lansoprazole

(+)-2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
103577-45-3
1H-Benzimidazole, 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-
1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-
2-?[[[3-?METHYL-?4-?(2,?2,?2-?TRIFLUOROETHOXY)-?2-?PYRIDINYL]METHYL]SULFINYL]-?1H-?BENZIMIDAZOLE
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)-1H-benzimidazole
2-(((3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole
2-(((3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl}sulfinyl)benzimidazol e
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methane}sulfinyl)-1H-1,3-benzodiazole
2-({[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl)-1H-benzimidazole
2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole;2-({3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl} sulphinylbenzimidazole
2-[({3-methyl-4-[(2,2,2-trifluoroethyl)oxy]pyridin-2-yl}methyl)sulfinyl]-1H-benzimidazole
2-[[ [3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoro-ethoxy)-2-pyridinyl]methyl]-sulfinyl]1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl] methyl] sulfinyl] benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]-methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]-1H-benzimidazole
2-[[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
2-[[[3-methyl-4-(2,2,2-trifluroethoxy)-2-pyridyl]methyl]sulfinyl]benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyrid-2-yl]methylsulfinyl]benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl]-1H-benzoimidazole
2-[[3-methyl-4-[2,2,2-tris(fluoranyl)ethoxy]pyridin-2-yl]methylsulfinyl]-1H-benzimidazole
2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzimidazole
2-[3-Methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-1H-benzoimidazole
2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)-pyridin-2-ylmethanesulfinyl]-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoro-ethoxy)pyridin-2-ylmethanesulfinyl]-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl-methanesulfinyl]-1H-benzimidazole
2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethanesulfinyl]-1H-benzimidazole
2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methanesulfinyl}-1H-1,3-benzodiazole
2-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methylsulfinyl}-1H-benzimidazole
577L453
A 65006
A-65006
A800764
AB0005100
AB00052388
AB00052388_18
AB00052388_19
AB00052388-17
AB2000063
Abbot Brand of Lansoprazole
ABT-006
AC1L1GX8
ACT03358
AG 1749
AG-1749
Agopton
Agopton (TN)
AKOS005554811
Almirall Brand of Lansoprazole
AN-15125
API0005388
Aprazol
Bamalite
BBL029072
BC208317
BDBM47032
BDBM50070208
BG0232
BIDD:GT0006
Bio-0824
Biuret Gr
Biuret Reagent Solution
Blason
BPBio1_001194
BRD-A49172652-001-05-7
BRN 4333393
BSPBio_001084
BSPBio_001830
C-21097
C16H14F3N3O2S
CAS-103577-45-3
CC-29843
CCG-39952
CG-4801
CHEBI:6375
CHEMBL480
cid_3883
CL0035
Compraz
CPD000058469
CS-1847
CTK8F0500
D00355
D0M4HV
Dakar
DB00448
DivK1c_000920
DR002018
DSSTox_CID_3200
DSSTox_GSID_23200
DSSTox_RID_76922
DTXSID4023200
EBD14854
EU-0100709
F2173-0222
FT-0082011
FT-0610894
GP5308
GTPL7208
HE130807
HE291353
HMS1571G06
HMS1922M04
HMS2052F05
HMS2093M07
HMS2098G06
HMS2234B10
HMS3262M19
HMS3264E12
HMS3269D15
HMS3371E21
HMS3394F05
HMS3654J17
HMS502N22
Hoechst Brand of Lansoprazole
Hormona Brand of Lansoprazole
HSDB 7204
HY-13662
I06-0018
IDI1_000920
Ilsatec
J-007154
KBio1_000920
KBio2_002060
KBio2_004628
KBio2_007196
KBio3_001330
KBioGR_001491
KBioSS_002060
Ketian
KS-00000VHO
L 8533
L0233
Lancid
Lanfast
Lanproton
LANSAPRAZOLE
Lansopep
Lansophed
Lansoprazol
Lansoprazol [INN-Spanish]
Lansoprazole (JAN/USP/INN)
Lansoprazole (JP17/USP/INN)
Lansoprazole [USAN:BAN:INN]
Lansoprazole for peak identification, European Pharmacopoeia (EP) Reference Standard
Lansoprazole, >=98% (TLC), powder
Lansoprazole, 98% 500mg
Lansoprazole, British Pharmacopoeia (BP) Reference Standard
Lansoprazole, European Pharmacopoeia (EP) Reference Standard
Lansoprazole, United States Pharmacopeia (USP) Reference Standard
Lansoprazole.
Lansoprazolum
Lansoprazolum [INN-Latin]
Lansox
Lansox (TN)
Lanston
Lanz
Lanzo
Lanzol
Lanzol-30
Lanzopral
lanzoprazole
Lanzor
Lanzul
Lapraz
Lasoprol
Lederle Brand of Lansoprazole
Limpidex
Lopac-L-8533
Lopac0_000709
LP00709
LS-33080
MCULE-8446262134
Mesactol
MFCD00866873
MJIHNNLFOKEZEW-UHFFFAOYSA-N
MLS-0003247.0001
MLS000069705
MLS000759405
MLS001074170
MLS001424235
MolPort-003-666-508
Monolitum
NC00411
NCGC00015615-01
NCGC00015615-02
NCGC00015615-03
NCGC00015615-04
NCGC00015615-05
NCGC00015615-06
NCGC00015615-07
NCGC00015615-08
NCGC00015615-09
NCGC00015615-10
NCGC00015615-11
NCGC00015615-12
NCGC00015615-14
NCGC00015615-15
NCGC00023826-03
NCGC00023826-04
NCGC00023826-05
NCGC00023826-06
NCGC00023826-07
NCGC00254925-01
NCGC00261394-01
NINDS_000920
NSC-758638
NSC-758710
NSC758638
NSC758710
Ogast
Ogast (TN)
Ogastro
Opera_ID_1676
Opiren
Pharmakon1600-01503926
Pharmakon1600-01504282
Prestwick0_001072
Prestwick1_001072
Prestwick2_001072
Prestwick3_001072
Prevacid
Prevacid (TN)
Prevacid 24HR
Prevacid Delayed Release
Prevacid I.V
Prevacid I.V.
Prevacid Iv
Prevacid NapraPAC
Prevacid SoluTab
Prevacid, Prevacid NapraPAC, Prevacid SoluTab, Lansoprazole
Prevacid;Prevacid NapraPAC;Prevacid SoluTab
PrevOnco
Prezal
Pro Ulco
Promeco
Promeco Brand of Lansoprazole
Promp
Prosogan
PubChem16834
RT-013461
s1354
Salvar Brand of Lansoprazole
SAM001246544
SBI-0050687.P003
SC-15158
SCHEMBL22365
SMR000058469
SPBio_000488
SPBio_002992
Spectrum_001580
SPECTRUM1503926
Spectrum2_000444
Spectrum3_000295
Spectrum4_000856
Spectrum5_001521
ST51015040
STK621169
Suprecid
TAK 390MR
TAK390MR
Takeda Brand of Lansoprazole
Takepron
Takepron (TN)
TAP Brand of Lansoprazole
Tecnobio Brand of Lansoprazole
TL8000155
Tox21_110184
Tox21_110184_1
Tox21_301023
Tox21_500709
Ulpax
Vinas Brand of Lansoprazole
Wyeth Brand of Lansoprazole
Zoprol
Zoton

US Patents and Regulatory Information for lansoprazole

+ Get email alerts for changes to this table

Glossary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Sandoz	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	090331-002	Apr 23, 2010	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Takeda Pharms Na	PREVACID	lansoprazole	FOR SUSPENSION, DELAYED RELEASE;ORAL	021281-002	May 3, 2001		DISCN	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Natco Pharma Ltd	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	203306-001	Jan 13, 2016		OTC	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Krka Tovarna Zdravil	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	091212-002	Sep 16, 2013	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Mylan Pharms Inc	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	090763-001	Nov 10, 2009	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Zydus Hlthcare	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	202366-002	Aug 19, 2013	AB	RX	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Perrigo R And D	LANSOPRAZOLE	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	202319-001	May 18, 2012		OTC	No	No	➤ Sign Up	➤ Sign Up				➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Expired US Patents for lansoprazole

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Takeda Pharms Usa	PREVACID	lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	021428-001	Aug 30, 2002	➤ Sign Up	➤ Sign Up
Takeda Pharms Usa	PREVACID	lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	021428-001	Aug 30, 2002	➤ Sign Up	➤ Sign Up
Takeda Pharms Na	PREVACID	lansoprazole	FOR SUSPENSION, DELAYED RELEASE;ORAL	021281-001	May 3, 2001	➤ Sign Up	➤ Sign Up
Takeda Pharms Usa	PREVACID	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	020406-002	May 10, 1995	➤ Sign Up	➤ Sign Up
Takeda Pharms Usa	PREVACID	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	020406-002	May 10, 1995	➤ Sign Up	➤ Sign Up
Takeda Pharms Usa	PREVACID	lansoprazole	TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE;ORAL	021428-002	Aug 30, 2002	➤ Sign Up	➤ Sign Up
Takeda Pharms Usa	PREVACID	lansoprazole	CAPSULE, DELAYED REL PELLETS;ORAL	020406-002	May 10, 1995	➤ Sign Up	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

International Patents for lansoprazole

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Japan	2000281564	➤ Sign Up
Portugal	1561458	➤ Sign Up
Australia	7875501	➤ Sign Up
Spain	2274625	➤ Sign Up
Denmark	1736144	➤ Sign Up
Slovenia	1100469	➤ Sign Up
Taiwan	I243062	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for lansoprazole

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
14/008	Ireland	➤ Sign Up	PRODUCT NAME: DEXLANSOPRAZOLE OR A SALT THEREOF; NAT REGISTRATION NO/DATE: PA1864/001/001-002;PA1864/002/001-002 20131125; FIRST REGISTRATION NO/DATE: 47911 47912 47913 47914 20130919
C0021	Belgium	➤ Sign Up	PRODUCT NAME: LANSOPRAZOLE + CLARITHROMYCINE + METRONIDAZOLE; REGISTRATION NO/DATE IN FRANCE: K 27 17033R DU 19960209; REGISTRATION NO/DATE AT EEC: K 27 17033R DU 19960209
C0021	Belgium	➤ Sign Up	PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description